MyCartis NV

Industriepark Zwijnaarde 7C, 9052 Zwijnaarde
Belgium

Telephone +32 9 2411164
Fax +32 9 2411169
info@mycartis.net
 http://www.mycartis.net

Product Categories

03 Diagnostics
03.02 Immunochemistry (Immunology)
03.02.07 Immuno assay systems
MEDICA 2017
Immuno assay systems

MyCartis technologies: accelerate innovation in biomarker analysis
MyCartis applications: improve bioassays
2 Products

03 Diagnostics
03.02 Immunochemistry (Immunology)
03.02.07 Immuno assay systems
03.02.07.12 Immunoassay with particle count
MEDICA 2017
Immunoassay with particle count

MyCartis technologies: accelerate innovation in biomarker analysis
MyCartis applications: improve bioassays
2 Products

03 Diagnostics
03.02 Immunochemistry (Immunology)
03.02.07 Immuno assay systems
03.02.07.15 Luminescence immunoassay (LIA, SPALT)
MEDICA 2017
Luminescence immunoassay (LIA, SPALT)

MyCartis technologies: accelerate innovation in biomarker analysis
MyCartis applications: improve bioassays
2 Products

03 Diagnostics
03.02 Immunochemistry (Immunology)
03.02.07 Immuno assay systems
03.02.07.16 Luminescence-enhanced immunoenzymatic assay (LIEMA)
MEDICA 2017
Luminescence-enhanced immunoenzymatic assay (LIEMA)

MyCartis technologies: accelerate innovation in biomarker analysis
MyCartis applications: improve bioassays
2 Products

03 Diagnostics
03.02 Immunochemistry (Immunology)
03.02.15 Rapid tests - Immunochemistry
MEDICA 2017
Rapid tests - Immunochemistry

MyCartis technologies: accelerate innovation in biomarker analysis
MyCartis applications: improve bioassays
2 Products

03 Diagnostics
03.02 Immunochemistry (Immunology)
03.02.16 Therapeutic drug monitoring
MEDICA 2017
Therapeutic drug monitoring

MyCartis technologies: accelerate innovation in biomarker analysis
MyCartis applications: improve bioassays
2 Products

03 Diagnostics
03.05 Infectious Immunology
03.05.08 Rapid tests - Infectious immunology
MEDICA 2017
Rapid tests - Infectious immunology

MyCartis technologies: accelerate innovation in biomarker analysis
MyCartis applications: improve bioassays
2 Products

ad: contact information

Company

Company details
About MyCartis
Biomarker analysis made fast and easy

The big revolution in healthcare today is that we are finally realizing that we are all equal, but not identical, certainly not at a molecular level.

MyCartis’ goal is to deliver innovative solutions for fast and cost effective identification of a patient’s specific signature of biomarkers. On our road to validate biomarkers on a larger scale, our intention is to build a bridge between research and medical practice by developing broadly available multiplexed biomarker solutions through technology (Evalution™) and bio-assays. The new multiplexing solution Evalution provides a ‘one technology fits all’ solution to enable researchers and assay developers to validate their biomarkers and to utilize and commercialize them. Evalution now provides anyone the opportunity to build multiplex assays for their biomarkers and to easily measure them in a fast, accurate and robust way.

The MyCartis technology jumps in exactly there where most biomarker programs end.

ad: contact information

MSD Europe bvba
Mona Lisa N.V.
Moments Furniture NV
Mercura Industries S.A.
MedicCleanAir, Division of Walsberghe nv

NAQI nv
NiniX Medical NV
Nipro Europe N.V.
NV NAQI Belgium
Obelis S.A. Obelis European Authorized Representative Center